Bristol-Myers Squibb Articles
Hana Biosci in-licenses menadione
23 October 2006
Amgen's Kevin Sharer is new president of PhRMA
16 October 2006
SMC approves Baraclude as HBV treatment for NHS in Scotland
16 October 2006
HIV drug Atripla submitted to EMEA
16 October 2006
B-MS and Gilead Sci sign Atripla accord
9 October 2006
Apotex' denied motion to restart Plavix sales
2 October 2006
New board chairman for PhRMA
25 September 2006
B-MS's Baraclude available in UK
25 September 2006
Stock Commentary - New York week to Sept 18, 2006
25 September 2006
Schering-Plough eyeing merger with Bristol-Myers Squibb?
25 September 2006
B-MS and Medivir to collaborate on HIV drug development
18 September 2006
UPDATE: Bristol-Myers Quibb fires CEO Peter Dolan and general counsel Richard Willard
18 September 2006
Report highlights gap in CV patient education
18 September 2006
13 new drugs added to Japan's NHI list
18 September 2006
Dolan ousted as B-MS CEO by board; Willard also goes
18 September 2006
Plavix gets EC nod for STEMI patients
18 September 2006
EC approves S-A/B-MS' combo antihypertensive
11 September 2006
Apotex denied stay of Plavix injunction
11 September 2006
Stock Commentary - New York week to Sept 4, 2006
11 September 2006
Eastern Europe, Middle East have highest death rates from CDD
11 September 2006
US Court stops Apotex' generic Plavix; Sanofi and B-MS shares rise despite no recall
11 September 2006
Stock Commentary - Europe - week to Aug 28, 2006
4 September 2006
Warner Chilcott's 2nd-qtr losses fall 34.8%
28 August 2006
Court deliberates Apotex' Plavix launch
28 August 2006
B-M S and Otsuka launch Abilify Discmelt
28 August 2006
B-MS board could replace CEO?
28 August 2006
Paris listing for Chinese pharma
28 August 2006
Update on Sanofi/B-MS Apotek injunction
28 August 2006
Stock Commentary - Europe - week to Aug 7, 2006
14 August 2006
Teva's net rockets 124% in 2nd-qtr 2006
14 August 2006
Stock Commentary - New York week to Aug 7, 2006
7 August 2006
Industry bodies oppose annual revision of Japan
7 August 2006
Plavix deal fails to get US antitrust OK
7 August 2006
ImClone's 2nd-qtr 2006 profit up 62% on Erbitux
31 July 2006
Stock Commentary - New York week to July 24, 2006
24 July 2006
European drugmakers ahead of US group, say analysts
24 July 2006
Atripla approved by FDA for use in HIV-1 therapy
17 July 2006
Stock Commentary - New York week to July 10, 2006
17 July 2006
Baraclude receives EC approval for hep B
10 July 2006
Canada
10 July 2006
Sprycel gets expedited approval for CML
10 July 2006
B-M S's dasatinib shows promise in CML studies
26 June 2006
Otsuka/B-MS Abilify gains Prix Galien
12 June 2006
Innovata transforms into profitable firm
12 June 2006
B-MS extends Lexicon alliance, pays $20M
5 June 2006
B-MS' Baraclude shows efficacy in HCV trial
5 June 2006
Development of B-MS' Pargluva discontinued
29 May 2006
US patient assistance programs under review
29 May 2006
Elizabeth Yamashita joins ImClone
22 May 2006
Daichii Sankyo's 2005/6 net income up 9.7%
22 May 2006
B-MS's Orencia performs well in trials
15 May 2006
Public Citizen calls on FDA to ban Tequin
8 May 2006
B-MS's earnings hit $714M in 1st-qtr
8 May 2006
B-MS and Gilead enter deal for HAART tablet
8 May 2006
Japan stock market week to May 1, 2006
8 May 2006
Watson ships generic Pravachol
1 May 2006
Stock Commentary - New York week to April 17, 2006
24 April 2006
Spanish pharma goes to court for hospital debts
17 April 2006
Rx price rise at "double inflation" says AARP
17 April 2006
Pharmacopeia licenses B-MS' DARA portfolio
10 April 2006
ImClone wins in product rights fight with Merck KGaA
10 April 2006
Retail drug sales up 5% in 2005
10 April 2006
Medarex begins Ipilimumab monotherapy trial
10 April 2006
B-MS to invest $200M in Puerto Rico plant expansion
3 April 2006
Medarex begins ipilimumab cancer trials
3 April 2006
Stock Commentary - New York week to March 27, 2006
3 April 2006
Strong animal data for SDP-103
3 April 2006
Sanofi and B-MS settle with Apotex over Plavix
27 March 2006
Prasugrel outperforms Plavix in study
20 March 2006
Strong results for B-MS/Otsuka's Abilify
20 March 2006
B-MS' dasatinib granted priority review by US FDA
13 March 2006
B-MS to build new $660M US biologics plant
13 March 2006
Erbitux approved by FDA in SCCHN
13 March 2006
Japan stock market week to Feb 20, 2006
27 February 2006
Aspen licenses B-M S HIV drug
27 February 2006
Drug prices lowered in French measures
13 February 2006
B-MS/Otsuka launch 2 new forms of Abilify
13 February 2006
B-MS settles class action on omapatrilat
13 February 2006
Stock Commentary - New York week to Jan 30
6 February 2006
Generics market takes off in France
6 February 2006
4th-qtr 2005 sales drop 1% for B-MS, as patents lost
30 January 2006
Good efficacy for Gilead Sci's ARV combo
30 January 2006
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
